Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074458 | SCV001240043 | likely pathogenic | Retinal dystrophy | 2017-05-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001862560 | SCV002152808 | pathogenic | not provided | 2022-10-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 866441). This variant has not been reported in the literature in individuals affected with EYS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys885*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). |
Baylor Genetics | RCV003462631 | SCV004193567 | likely pathogenic | Retinitis pigmentosa 25 | 2022-09-07 | criteria provided, single submitter | clinical testing |